@cristinatomasi's hormone therapy claims, fact-checked

What did @cristinatomasi actually say?

This is where we have to be straightforward with you: the transcript provided for this video is incoherent. It references a "coronavirus pandemic" repeatedly and mentions cancer in a non-clinical context, bearing no relationship to the caption's topic of hormone replacement therapy (HRT, or TOS in Italian) duration. The caption, however, does make a specific and testable claim: that women can take HRT "for life" with no maximum time limit, citing support from major international menopause societies.

Because the caption contains the actual medical claim being promoted to 141,000 viewers, that is what we are fact-checking here. The claim is: HRT has no upper time limit and can be continued indefinitely unless a contraindication appears.

Does the science back this up?

Partially, yes, but the framing is more confident than the evidence warrants. The major menopause societies have indeed moved away from arbitrary cut-off points, but "no maximum time limit" is not the same as "proven safe forever."

The 2022 position statement from the Menopause Society (formerly NAMS) and the 2023 guidance from the British Menopause Society both state that duration of HRT should be individualized, not capped at a fixed number of years. The old five-year or ten-year rules were largely a reaction to a misreading of the Women's Health Initiative (WHI) data from 2002. That study's findings were later shown to be specific to older women starting HRT more than ten years after menopause, not to women who begin therapy at the time of menopause (Manson et al., 2013, JAMA Internal Medicine).

However, long-term use, particularly of combined estrogen-progestogen therapy, is still associated with a small but real increased risk of breast cancer. The 2019 Collaborative Group on Hormonal Factors in Breast Cancer meta-analysis (Lancet) found that breast cancer risk increased with duration of use and persisted for more than ten years after stopping. That is not a reason to automatically refuse long-term HRT, but it is a reason not to present the situation as settled.

What did they get wrong (or right)?

Credit where it is due: the claim that international menopause societies no longer endorse a hard stop on HRT duration is accurate. The British Menopause Society, the International Menopause Society, and the Menopause Society all support individualized decision-making over blanket time limits.

What is misleading is the phrase "no maximum time limit" presented without qualification. For most healthy women who start HRT around menopause onset, long-term use appears to carry manageable risks. For women with certain risk profiles, including BRCA mutations, a personal history of estrogen-receptor-positive breast cancer, or certain cardiovascular conditions, indefinite continuation is not appropriate. Saying "the science is clear" on this topic overstates the consensus. Long-term safety data beyond 20 years of continuous use is genuinely limited, and researchers like Collaborative Group on Hormonal Factors are still publishing risk refinements as of 2019 and beyond.

The caption also uses the hashtag "ormonibioidentici" (bioidentical hormones), which adds a separate layer of complexity. Compounded bioidentical hormones are not equivalent to regulated HRT products and carry their own unresolved safety questions that the caption does not address.

What should you actually know?

If you are a woman considering long-term HRT, here is what the current evidence actually supports. Duration should be decided between you and a clinician based on your symptom burden, your individual risk factors, and regular re-evaluation. There is no arbitrary age or year count that automatically means you must stop.

That said, "no limit" is not the same as "no monitoring." Annual review is the standard of care in most guidelines. The Lancet 2019 meta-analysis is real and relevant: ten or more years of combined HRT use does carry a measurable breast cancer signal, even if absolute risk for many individuals remains low. Body-identical regulated products (like 17-beta estradiol and micronized progesterone) have a more favorable safety profile than older synthetic progestogens, according to data reviewed by L'Hermite (2017, Climacteric). But that is not the same as zero risk.

If you see a claim on social media that makes long-term HRT sound unconditionally safe, that should prompt a conversation with your doctor, not reassurance.

Bottom line

The core message here, that HRT does not have an automatic expiration date, is defensible and reflects a genuine shift in clinical guidance. The delivery, framing it as a simple, settled matter with no caveats, does a disservice to the complexity of the evidence and to the women watching this video.